Interactions of the PPARγ2 polymorphism with fat intake affecting energy metabolism and nutritional outcomes in obese women

Annals of Nutrition and Metabolism

Volumn 57, Issue 3-4, 2010, Pages 242-250

  Rosado, Eliane L ^a,e   Bressan, Josefina ^b   Martínez, J Alfredo ^c   Marques Lopes, Iva ^d  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

^c UNIVERSITY OF NAVARRA   (Spain)

^d UNIVERSITY OF ZARAGOZA   (Spain)

^e Departamento de Nutrição e Dietética   (Brazil)

Author keywords

Body composition; Energy metabolism; Fat diet; Obesity; PPAR 2

Indexed keywords

MONOUNSATURATED FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2;

ADULT; ANTHROPOMETRY; ARTICLE; BODY COMPOSITION; BODY MASS; ENERGY EXPENDITURE; ENERGY METABOLISM; FAT INTAKE; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; LIPID DIET; LIPID OXIDATION; LOW CALORY DIET; MAJOR CLINICAL STUDY; OBESITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESPIRATORY QUOTIENT; SPAIN;

EID: 78649769044     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000322187     Document Type: Article

References (49)

1. World Health Organization: Statistics of obesity and overweight in the world. 2006. http://www.who.int/mediacentre/factsheets (accessed in January 5, 2009).
2. Walley AJ, Asher JE, Froguel P: The genetic contribution to non-syndromic human obesity. Nat Rev Genet 2009; 10: 431-442.
3. Marti A, Martínez-Gonzáles MA, Martínez JA: Interaction between genes and lifestyle factors on obesity. Proc Nutr Soc 2008; 67: 1-8.
4. Heikkinnen S, Auwerx J, Argmann CA: PPARgamma in human and mouse physiology. Biochim Biophys Acta 2007; 1771: 999-1013.
5. Boon YK, Najimudin N, Muhammand TS: The PPARgamma coding region and its role in visceral obesity. Biochem Biophys Res Commun 2008; 27: 177-179.
6. Rangwaia SM, Lazar MA: Peroxisome proliferator- activated receptors gamma in diabetes and metabolism. Trends Pharmacol Sci 2004; 25: 331-336.
7. Meirhaeghe A, Fajas L, Helbecque N, Cottel D, Auwerx J, Deeb SS, Amouyel P: Impact of the peroxisome proliferator activated receptor γ 2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus. Int J Obes Relat Metab Disord 2000; 24: 195-199.
8. Kersten S, Desvergne B, Wahli W: Roles of PPARs in health and diseases. Nature 2000; 405: 421-424.
9. Kubota N, Terauchi Y, Miki H, Tamemoto H, Yamauchi T, Komeda K, et al: PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell 1999; 4: 597-609.
10. Houseknecht KL, Cole BM, Steele PJ: Peroxisome proliferator-activated receptor gamma (PPAR γ ) and its ligands: a review. Domest Anim Endocrinol 2002; 22: 1-23.
11. Azcárate TM, Moral AM, Hernández AM: Estudios genéticos de la obesidad en humanos. Med Clin 2000; 115: 103-110.
12. Vidal-Puig A, Jiménez-Liñan M, Lowell BB, Hamann A, Hu E, Spiegelman B, Flier JS, Moller DE: Regulation of PPAR g gene expression by nutrition and obesity in rodents. J Clin Invest 1996; 97: 2553-2561.
13. Deeb SS, Fajas L, Nemoto M, Pihlajamäki J, Mykkänen L, Kuusisto J, Laakso M, Fujimoto W, Auwerx J: A Pro12Ala substitution in PPARγ2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity. Nat Genet 1998; 20: 284-287.
14. Valve R, Sivenius K, Miettinen R, Pihlajamäki J, Rissanen A, Deeb SS, Auwerx J, Uusitupa M, Laakso M: Two polymorphisms in the peroxisome proliferator-activated receptor- γ gene are associated with severe overweight. J Clin Endocrinol Metab 1999; 84: 3708-3712.
15. Barroso I, Gurnell M, Chowley VE, Agostini M, Schwabe JW, Soos MA, Maslen GLI, Williams TD, Lewis H, Schafer AJ, Chatterjee VK, O'Rahilly S: Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension. Nature 1999; 402: 880-883.
16. Arner P: Obesity - a genetic disease of adipose tissue? Br J Nutr 2000; 83(suppl 1):S9-S16.
17. Koch M, Rett K, Maerker E, Volk A, Haist K, Deninger M, Renn W, Häring HU: The PPAR γ 2 amino acid polymorphism Pro- 12Ala is prevalent in offspring of type II diabetic patients and is associated to increased insulin sensitivity in a subgroup of obese subjects. Diabetologia 1999; 42: 758-762.
18. Pihlajamaki J, Miettinen R, Valve R, Karjalainen L, Mykkänen L, Kuusisto J, Deeb S, Auwerx J, Laakso M: The Pro12Ala substitution in the peroxisome proliferator-activated receptor gamma 2 is associated with an insulin- sensitive phenotype in families with familial combined hyperlipidemia and in nondiabetic elderly subjects with dyslipidemia. Atherosclerosis 2000; 15: 567-574.
19. Stumvoll M, Wahl HG, Loblein K, Becker R, Machicao F, Jacob S, Häring H: Pro12Ala polymorphism in the peroxisome proliferator- activated receptor- γ 2 gene is associated with increase antilipolytic insulin sensitivity. Diabetes 2001; 50: 876-881.
20. Luan J, Browne PO, Harding AH, Halsall DJ, O'Rahilly S, Chatterjee VK, Wareham NJ: Evidence for gene-nutrient interaction at the PPAR γ locus. Diabetes 2001; 50: 686-689.
21. Beamer B, Yen CJ, Andersen R, Muller D, Elahi D, Cheskin LJ, Andres R, Roth J, Shuldiner AR: Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor γ 2 gene with obesity in two Caucasian populations. Diabetes 1998; 47: 1806-1808. (Pubitemid 28476259)
22. Nicklas BJ, Rossun EF, Berman DM, Ryan AS, Dennis KE, Shuldiner AR: Genetic variation in the peroxisome proliferator-activated receptor- γ 2 gene (Pro12Ala) affects metabolic responses to weight loss and subsequent weight regain. Diabetes 2001; 50: 2172-2176.
23. Blum K, Chen TJ, Meshkin B, Blum SH, Mengucci JF, Notaro A, Arcuri V, Waite RL, Braverman ER: The PPAR- γ Pro12Ala allele polymorphism of the peroxisome proliferator- activated receptor (γ ) gene (PPARG2) is a risk factor with a self-identified obese Dutch population. Gene Ther Mol Biol 2007; 11: 37-42.
24. Martí A, Corbalán MS, Martínez-González MA, Forga L, Martínez JA: CHO intake alters obesity risk associated with Pro12Ala polymorphism of PPAR γ gene. J Physiol Biochem 2002; 58: 219-220.
25. Rosado EL, Bressan J, Martins MF, Cecon PR, Martínez JA: Polymorphism in the PPARgamma2 and beta2-adrenergic genes and diet lipid effects on body composition, energy expenditure and eating behavior of obese women. Appetite 2007; 49: 635-643.
26. Miles LE, Lipschitz DA, Bieber CP, Cook JD: Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 1974; 61: 209-224.
27. Geissler CA, Miller DS, Shah M: The daily metabolic rate of the post-obese and the lean. Am J Clin Nutr 1987; 45: 914-920.
28. Gibson RS: Principles of Nutritional Assessment. New York, Oxford University Press, 2005, p 691.
29. Bray GA, Gray DS: Obesity I: pathogenesis. West J Med 1988; 149: 429-441.
30. World Health Organization: Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, WHO, 1998.
31. Weinsier RL, Nelson KM, Hensrud DD, Darnell BE, Hunter GR, Schutz Y: Metabolic predictors of obesity: contribution of resting energy expenditure, thermic effect of food, and fuel utilization to four-year weight gain of post-obese and never-obese women. J Clin Invest 1995; 95: 980-985.
32. Després JP, Lemieux I, Prud'homme D: Treatment of obesity: need to focus on high risk abdominally obese patients. BMJ 2001; 322: 716-720.
33. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI: Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41: 810-817.
34. Ferrannini E: The theoretical bases of indirect calorimetry: a review. Metabolism 1988; 37: 287-301.
35. WHO: Energy and protein requirements. Report of a joint FAO/WHO/UNU expert consultation. Technical Report Series 724. Geneva, WHO, 1985.
36. Food and Nutrition Board, National Research Council, National Academy of Sciences: Recommended Dietary Allowances. Washington, National Academy Press, 2002.
37. Mullis KB, Falooma FA: Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol 1987; 155: 335-350.
38. GenBank: DNA. AB005520. Homo sapiens ppar.[gi:2605488]. 2010. http://www.ncbi. nlm.nih.gov/genbank (accessed January 24, 2010).
39. van Rossum CT, Hoebee B, Seidell JC Bouchard C, van Baak MA, de Groot CP, Chagnon M, de Graaf C, Saris WH: Genetic factors as predictors of weight gain in young adult Dutch men and women. Int J Obes Relat Metab Disord 2002; 26: 517-528.
40. Damcott CM, Moffett SP, Feingold E, Barmada MM, Marshall JA, Hamman RF, Ferrell RE: Genetic variation in fatty acid-binding protein-4 and peroxisome proliferatoractivated receptor gamma interactively influence insulin sensitivity and body composition in males. Metabolism 2004; 53: 303-309.
41. Memisoglu A, Hu FB, Hankinson SE, Manson JE, De Vivo I, Willett WC, Hunter DJ: Interaction between a peroxisome proliferator- activated receptor gamma gene polymorphism and dietary fat intake in relation to body mass. Hum Mol Genet 2003; 12: 2923-2929.
42. Casas-Agustench P, López-Uriarte P, Bulló M, Ros E, Gómez-Flores A, Salas-Salvadó J: Acute effects of three high-fat meals with different fat saturations on energy expenditure, substrate oxidation and satiety. Clin Nutr 2009; 28: 39-45.
43. Clarke SD, Gasperikova D, Nelson C, Lapillonne A, Heird WC: Fatty acid regulation of gene expression: a genomic explanation for the benefits of the Mediterranean diet. Ann NY Acad Sci 2002; 967: 283-298.
44. World Health Organization/Food and Agricultural Organization: Diet, nutrition and the prevention of chronic disease. WHO Technical Report Series 916. Geneva, WHO, 2003.
45. Robitaille J, Depress JP, Perusse L, Vohl MC: The PPAR-P12A polymorphism modulates the relationship between dietary fat intake and components of the metabolic syndrome: results from the Quebec Family Study. Clin Genet 2003; 63: 109-116.
46. Nelson TL, Fingerlin TE, Moss L, Barmada MM, Ferrell RE, Norris JM: The PPARgamma Pro12Ala polymorphism is not associated with body mass index or waist circumference among Hispanics from Colorado. Ann Nutr Metab 2007; 51: 252-257.
47. Sauma L, Stenkula KG, Kjolhede P, Stralfors P, Soderstrom M, Nystrom FH: PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids. Nutrition 2006; 22: 60-68.
48. Rosado EL, Bressan J, Martinez JA, Martins MF, Cecon PR: Effect of diet and PPARgamma2 and beta2-adrenergic receptor genes on energy metabolism and body composition in obese women. Nutr Hosp 2006; 21: 317-331.
49. Marti A, Goyenechea E, Martínez JA: Nutrigenetics: a tool to provide personalized nutritional therapy to the obese. World Rev Nutr Diet 2010; 101: 21-33.